Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| RGS2 | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 87.30 | Evidence | |||||
| RGS2 | HCK | N/A | 84.00 | Evidence | |||||
| RGS2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 59.5 | Evidence | |||||
| RGS2 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 32.90 | Evidence | |||||
| RGS2 | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 32.90 | Evidence | |||||
| RGS2 | LTB4R | LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 | 24.90 | Evidence | |||||
| RGS2 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 22.00 | Evidence | |||||
| RGS2 | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 18.40 | Evidence | |||||
| RGS2 | PTGIR | PTGIR, PRIPR: Prostacyclin receptor | 18.40 | Evidence | |||||
| RGS2 | COPA | COPA: Coatomer subunit alpha | 15.10 | Evidence | |||||
| RGS2 | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 10.40 | Evidence | |||||
| RGS2 | TBXA2R | TBXA2R: Thromboxane A2 receptor | 9.92 | Evidence | |||||
| RGS2 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 7.61 | Evidence | |||||
| RGS2 | CHRM2 | CHRM2: Muscarinic acetylcholine receptor M2 | 6.62 | Evidence | |||||
| RGS2 | F2R | F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor | 6.52 | Evidence | |||||
| RGS2 | HTR6 | HTR6: 5-hydroxytryptamine receptor 6 | 6.52 | Evidence | |||||
| RGS2 | HTR2C | HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C | 6.52 | Evidence | |||||
| RGS2 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 6.24 | Evidence | |||||
| RGS2 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 5.9 | Evidence | |||||
| RGS2 | FFAR2 | FFAR2, GPR43: Free fatty acid receptor 2 | 4.80 | Evidence | |||||
| RGS2 | GNAI2 | Galphai2 protein | 4.36 | Evidence | |||||
| RGS2 | CAMKK1 | N/A | 3.34 | Evidence | |||||
| RGS2 | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 3.28 | Evidence | |||||
| RGS2 | FPR1 | FPR1: fMet-Leu-Phe receptor | 3.11 | Evidence | |||||
| RGS2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 3.07 | Evidence | |||||
| RGS2 | DLG1 | N/A | 2.55 | Evidence | |||||
| RGS2 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 2.55 | Evidence | |||||
| RGS2 | CRKL | CRKL: Crk-like protein | 2.34 | Evidence | |||||
| RGS2 | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 2.13 | Evidence | |||||
| RGS2 | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 1.98 | Evidence | |||||
| RGS2 | RELA | RELA, NFKB3: Transcription factor p65 | 1.97 | Evidence | |||||
| RGS2 | C9orf47 | EDG3: Sphingosine 1-phosphate receptor Edg-3 | 1.91 | Evidence | |||||
| RGS2 | GPR62 | GPR62: Probable G-protein coupled receptor 62 | 1.91 | Evidence | |||||
| RGS2 | HTR4 | HTR4: 5-hydroxytryptamine receptor 4 | 1.91 | Evidence | |||||
| RGS2 | CNR1 | CNR1, CNR: Cannabinoid receptor 1 | 1.91 | Evidence | |||||
| RGS2 | FFAR1 | FFAR1, GPR40: Free fatty acid receptor 1 | 1.91 | Evidence | |||||
| RGS2 | STUB1 | STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1 | 1.9 | Evidence | |||||
| RGS2 | RGS4 | RGS4: Regulator of G-protein signaling 4 | 1.51 | Evidence | |||||
| RGS2 | RGS16 | RGS16, RGSR: Regulator of G-protein signaling 16 | 1.51 | Evidence | |||||
| RGS2 | MYF5 | MYF5: Myogenic factor 5 | 1.30 | Evidence | |||||
| RGS2 | GNAQ | GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha | 1.29 | Evidence |
O
|
||||
| RGS2 | GNA15 | GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit | 1.29 | Evidence |
O
|
||||
| RGS2 | CNR2 | CNR2: Cannabinoid receptor 2 | 1.27 | Evidence | |||||
| RGS2 | GALR2 | GALR2, GALNR2: Galanin receptor type 2 | 1.25 | Evidence | |||||
| RGS2 | PDLIM5 | PDLIM5, ENH: PDZ and LIM domain protein 5 | 1.18 | Evidence | |||||
| RGS2 | TLR2 | TLR2, TIL4: Toll-like receptor 2 precursor | 1.14 | Evidence | |||||
| RGS2 | ARAF | ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase | 1.13 | Evidence | |||||
| RGS2 | CHRM3 | CHRM3: Muscarinic acetylcholine receptor M3 | 1.13 | Evidence | |||||
| RGS2 | HRH4 | HRH4, GPCR105: Histamine H4 receptor | 1.13 | Evidence | |||||
| RGS2 | C5AR1 | C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor | 1.03 | Evidence | |||||